Werbung
Werbung

EDSA

EDSA logo

Edesa Biotech, Inc. Common Shares

1.51
USD
Gesponsert
0.00
0.00%
09. Jan., 15:56 UTC -5
Geschlossen
exchange

Nach-Markt

1.51

0.00
0.00%

EDSA Ergebnisberichte

Positives Überraschungsverhältnis

EDSA übertreffen die 19 der letzten 29Schätzungen.

66%

Nächster Bericht

Datum des nächsten Berichts
12. Feb. 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.28
Implizierte Änderung von Q4 25 (Revenue/ EPS)
--
/
-12.50%
Implizierte Änderung von Q1 25 (Revenue/ EPS)
--
/
-41.67%

Edesa Biotech, Inc. Common Shares earnings per share and revenue

On 12. Dez. 2025, EDSA reported earnings of -0.32 USD per share (EPS) for Q4 25, missing the estimate of -0.27 USD, resulting in a -17.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -16.09% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.28 USD, with revenue projected to reach -- USD, implying an decrease of -12.50% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q4 2025, Edesa Biotech, Inc. Common Shares reported EPS of -$0.32, missing estimates by -17.65%, and revenue of $0.00, 0% as expectations.
The stock price moved down -16.09%, changed from $1.74 before the earnings release to $1.46 the day after.
The next earning report is scheduled for 12. Feb. 2026.
Based on 4 analysts, Edesa Biotech, Inc. Common Shares is expected to report EPS of -$0.28 and revenue of -- for Q1 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung